inōtiv Corporate Presentation June 2023
Who We Are
Since new leadership joined in 2018, Inotiv, Inc. has become
a global CRO (contract research organization), offering a
comprehensive suite of research science, models and
services in the discovery and development of novel
therapeutics, comprised of two segments:
DSA
RMS
Discovery and Safety
Assessment
Research Models and
Services
Our transformation into a midsized CRO has included 14
completed acquisitions across both segments and the
organic launches of 8 new services within our DSA segment.
Inotiv now serves over ~3,500 clients globally, quickly
emerging as a leader in the CRO space.
3 |
Annual Revenue ($ millions)
CAGR +109%
$89.6
$60.5
$43.6
$547.7
FY'19
FY'20
FY'21
FY'22
CORPORATE PRESENTATION
inōtiv
analyze, answer. advance.View entire presentation